CompanyGraph
Shanghai Runda Medical Technology Co., Ltd.
603108 · SSE · China
rundamedical.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $1.02B, above the global median of $520.53M
- PositionDebt-to-equity is 1.42×, higher than 95% of its Diagnostics & Research peers (median 0.16×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.86BCNY868.83M · vs all stocks (USD)
Revenue (TTM)
6.85BCNY1.02B · vs all stocks (USD)
Profit Margin
-7.78%vs Diagnostics & Research peers
Beta
0.5390xvs all stocks
52-Week Change
-46.52%vs all stocks
Market Capitalization
5.86BCNY868.83M · vs all stocks (USD)
Enterprise Value
12.90BCNY1.91B · vs all stocks (USD)
Forward P/E
13.34xvs Diagnostics & Research peers
Price to Sales (TTM)
0.8600xvs Diagnostics & Research peers
Price to Book (MRQ)
1.58xvs Diagnostics & Research peers
Enterprise to Revenue
1.88xvs Diagnostics & Research peers
Enterprise to EBITDA
43.23xvs Diagnostics & Research peers
Gross Margin
23.24%vs Diagnostics & Research peers
Profit Margin
-7.78%vs Diagnostics & Research peers
Operating Margin
1.10%vs Diagnostics & Research peers
Return on Assets (TTM)
0.11%vs Diagnostics & Research peers
Return on Equity (TTM)
-9.68%vs Diagnostics & Research peers
Revenue (TTM)
6.85BCNY1.02B · vs all stocks (USD)
Revenue per Share (TTM)
11.53CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-9.10%vs Diagnostics & Research peers
Gross Profit (TTM)
1.50BCNY222.89M · vs all stocks (USD)
EBITDA (TTM)
581.92MCNY86.30M · vs all stocks (USD)
Net Income (TTM)
-532.70MCNY-79.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-29.27%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
566.73MCNY84.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
405.99MCNY60.21M · vs all stocks (USD)
Payout Ratio
166.67%vs Diagnostics & Research peers
Minority Interest (Equity)
1.10BCNYFY2025 · Dec 31, 2025Revenue
7.00BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.50BCNYFY2025 · Dec 31, 2025Gross Profit
1.50BCNYFY2025 · Dec 31, 2025Operating Income
204.62MCNY30.35M · vs all stocks (USD)
Pre-tax Income
-460.64MCNYFY2025 · Dec 31, 2025Income Tax Expense
57.51MCNYFY2025 · Dec 31, 2025Net Income
-518.15MCNYFY2025 · Dec 31, 2025EBIT
-181.71MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
581.92MCNYFY2025 · Dec 31, 2025Research & Development
108.01MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
438.77MCNYFY2025 · Dec 31, 2025Other Operating Expenses
112.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
278.93MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.9100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.9100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
602.63MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
602.63MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-518.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-30.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-858.12MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.09BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
667.05MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-518.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
307.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-70.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-577.67MCNYFY2025 · Dec 31, 2025Capital Expenditures
-232.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-559.78MCNYFY2025 · Dec 31, 2025Sale of Investments
552.12MCNYFY2025 · Dec 31, 2025Other Investing Activity
856.96KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-239.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
7.58BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.69BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-281.35MCNYFY2025 · Dec 31, 2025Other Financing Charges
-92.19MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-479.76MCNYFY2025 · Dec 31, 2025Shares Outstanding
603.70MSharesUpdated Aug 19, 2026Float Shares
419.80MSharesUpdated Aug 19, 2026% Held by Insiders
31.76%vs all stocks
% Held by Institutions
2.30%vs all stocks
Total Cash (MRQ)
970.03MCNY143.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.61CNYUpdated Aug 19, 2026Total Debt (MRQ)
6.79BCNY1.01B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.42xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.08xvs Diagnostics & Research peers
Book Value per Share (MRQ)
6.17CNYUpdated Aug 19, 2026Total Assets
13.42BCNY1.99B · vs all stocks (USD)
Total Current Assets
8.52BCNYFY2025 · Dec 31, 2025Total Liabilities
8.54BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.90BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
857.58MCNYFY2025 · Dec 31, 2025Total Current Liabilities
7.68BCNYFY2025 · Dec 31, 2025Cash
667.05MCNYFY2025 · Dec 31, 2025Cash Equivalents
348.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.02BCNYFY2025 · Dec 31, 2025Other Short-term Investments
129.80MCNYFY2025 · Dec 31, 2025Accounts Receivable
4.46BCNYFY2025 · Dec 31, 2025Inventory
1.73BCNYFY2025 · Dec 31, 2025Accounts Payable
1.22BCNYFY2025 · Dec 31, 2025Short-term Debt
6.06BCNYFY2025 · Dec 31, 2025Other Current Liabilities
21.46MCNYFY2025 · Dec 31, 2025Long-term Debt
708.16MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.69MCNYFY2025 · Dec 31, 2025Common Stock (Book)
603.68MCNYFY2025 · Dec 31, 2025Retained Earnings
1.77BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.88BCNY723.92M · vs all stocks (USD)
52-Week Low
8.70CNYUpdated Aug 19, 202652-Week High
20.77CNYUpdated Aug 19, 202652-Week Change
-46.52%vs all stocks
Beta
0.5390xvs all stocks
50-Day MA
9.86CNYUpdated Aug 19, 2026200-Day MA
13.59CNYUpdated Aug 19, 2026Avg 10-Day Volume
25.02MSharesUpdated Aug 19, 2026Avg 30-Day Volume
24.79MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.8900CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Diagnostic
Declining With Price Stretched Below 1Y Mean
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 1.42×, higher than 95% of its Diagnostics & Research peers (median 0.16×)Significant
Debt-to-equity: 1.42Industry median: 0.16Industry P95: 1.36Peers compared: 31.00
Financial Health
Altman Z-Score 1.15: grey zoneSignificant
Altman Z-Score: 1.15
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $1.02B, above the global median of $520.53MNotable
Revenue (USD): 1,015,438,279.373Global Median: 520,528,949.311
Levered free cash flow is $60.21M, above the global median of $16.24MNotable
Levered free cash flow (USD): 60,209,007.485Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Dongguan Mentech Optical & Communication Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou Galaxy Century Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Migao Group Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
ProFrac Holding Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sunrise Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Safilo Group S.p.A.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Winnebago Industries, Inc.
Tier 1ProductionThroughput-Bound ConversionRiskFlow
Yueyang Forest & Paper Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sudarshan Chemical Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Zhejiang Truelove Vogue Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Vats Liquor Chain Store Co., Ltd.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDeclining With Price Stretched Below 1Y Mean
Hubei Broadcasting & Television Information Network Co., Ltd.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDeclining With Price Stretched Below 1Y Mean
Shanghai AJ Group Co., Ltd.
2 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDeclining With Price Stretched Below 1Y Mean